TD Cowen Maintains Buy on GRAIL, Raises Price Target to $180

10/13/2026
Impact: 85
Healthcare

TD Cowen analyst Dan Brennan has maintained a Buy rating on GRAIL (NASDAQ: GRAL) and increased the price target from $88 to $180.

AI summary, not financial advice

Share: